NEW YORK (GenomeWeb News) – Joshua Sharfstein, who recently was appointed by President Barack Obama to serve as deputy commissioner of the US Food and Drug Administration, this morning takes over as acting FDA commissioner.
Sharfstein will hold that title while confirmation hearings are held for Margaret Hamburg, who was named by Obama to head the agency.
He takes over the interim role from Frank Torti, who has served as acting FDA commissioner since January.
Sharfstein has been health commissioner for the city of Baltimore for the past three years. He also is a former investigator for the Government Reform and Oversight Committee, serving under Rep. Henry Waxman (D - Calif.).